Blind Spots: Exploring What We Cannot See

Windrose Recovery
  • 5.0 (21)
  • MENTAL HEALTH
  • UPDATED BIMONTHLY
Blind Spots: Exploring What We Cannot See

Exploring blind spots that exist in the cultural, relational, and therapeutic process, host Dr. Chantelle Thomas will have candid discussions that delve into the more challenging aspects of self-discovery. Filled with engaging and straightforward conversation, each episode features conversations with well-respected experts who examine what is commonly overlooked in the intricate and often inter-connected world of recovery, trauma and wellness. Join Windrose Recovery and its Executive Clinical Director Dr. Chantelle Thomas as we attempt to uncover barriers to personal growth from the perspective of both clients and clinicians.

  1. SEP 13

    Expanding Access to (Psychedelic) Care

    Dr. Chantelle Thomas chats with Ronica Mukerjee, DNP, MsA, FNP-BC, PMHNP-BC, LAc, a family and psychiatric nurse practitioner and acupuncturist, discusses her multifaceted work, including holistic psychiatry, gender-affirming care, and psychedelic-assisted treatment. She highlights her work with refugees, particularly Haitians, and her efforts to establish a free trans care program. Ronica shares her experiences in Tijuana during COVID-19, providing medical care in a chaotic environment. She emphasizes the need for inclusive, culturally sensitive approaches to mental health and psychedelic therapy, particularly for marginalized communities. Ronica is also developing educational resources to make psychedelic work accessible to a broader audience. (0:00:34) Introduction (0:03:14) Work in Mexico and Refugee Health (0:09:45) Challenges and Experiences in Tijuana (0:25:16) Psychedelic-Assisted Treatment and Its Impact (0:47:41) Challenges in Psychedelic Research and Access (0:49:39) The Role of Psychedelics in Mental Health (0:50:05) The Future of Psychedelic Therapy and Research Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: https://windroserecovery.com/ Integrata:  www.integratahealing.com Ronica Mukerjee, DNP, MsA, FNP-BC, PMHNP-BC, LAc, Assistant Professor of Nursing at CUMC: https://www.nursing.columbia.edu/profile/ronica-mukerjee-dnp Lykos: https://lykospbc.com

    1h 14m

  2. JUL 26

    Therapy Unblinded: Inside MDMA Research Part 2

    Dr. Chantelle Thomas and Dr. Ingmar Gorman discuss the safety and ethical considerations of MDMA-assisted psychotherapy for PTSD, including standardization, non-directive approach, and adherence to therapy protocol. They also explore complex power dynamics in therapeutic relationships, ethical nuances of supporting participants in psychedelic studies, and the importance of representing a diverse population in psychedelic trials.  (00:00:00) Introduction (00:10:30) Therapist-participant relationships in psychedelic-assisted therapy trial. (00:14:58) Challenges in supporting participants in psychedelic studies after the end of the trial. (00:23:11) Standardizing therapy for MDMA-assisted therapy trial. (00:32:11) The importance of non-directional support. (00:36:37) Operationalizing therapy techniques to ensure consistency and address power imbalances. (00:43:06) Psychedelic therapy adherence and rating systems. (00:50:08) Therapist flexibility in the trial. (00:59:41) Inclusion of diverse participants. Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: https://windroserecovery.com/ Integrata:  www.integratahealing.com Dr. Ingmar Gorman: https://www.ingmargorman.com/about Lykos: https://lykospbc.com

    1h 4m

  3. JUN 26

    Therapy Unblinded: Inside MDMA Research

    Dr. Chantelle Thomas talks to Dr. Ingmar Gorman about concerns and methodological critiques of MDMA-assisted therapy, including historical boundary violations and inappropriate treatment of participants. They also address adverse event management, inner healing intelligence, and the importance of adapting language and approach to resonate with each individual participant. Additionally, they discuss the ethical complexities of conducting clinical trials, including balancing participant privacy and safety with the need to share information for public advocacy and education. Finally, they delve into the intricacies of trauma therapy, including personal experiences, clinical approaches, and limitations, and emphasize the need for a paradigm shift in clinical practice, prioritizing the client's agency and internal resources for healing. (0:00:00) Introduction (0:10:14) FDA's decision on MDMA therapy for PTSD, with focus on ICER and FDA advisory panel reports. (0:15:21) The benefits and challenges of a clinical trial for treating PTSD. (0:21:03) Conducting clinical trials with nuanced considerations for ethics, regulations, and participant experiences. (0:31:52) Adverse events in the trial, with concerns about data accuracy and researcher bias. (0:44:02) Suicidal ideation and its impact on mental health treatment. (0:52:23) Clinical trial design and unblinding issues in PTSD treatment study. (0:59:26) MDMA therapy for trauma, participants' experiences and criticisms. (1:05:31) Trauma therapy effectiveness and the importance of considering other measures beyond PTSD symptoms. (1:10:36) Inner healing intelligence in MDMA-assisted therapy. (1:29:51) MDMA-assisted therapy for PTSD, including resourcing and adherence. Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: https://windroserecovery.com/ Integrata:  www.integratahealing.com Dr. Ingmar Gorman: https://www.ingmargorman.com/about Lykos: https://lykospbc.com

    1h 38m

  4. MAY 24

    "Setting the Stage" for Psychedelic Therapy with Chris Stauffer

    Dr. Chantelle Thomas talks to Dr. Chris Stauffer about his unique path to becoming a provider of psychedelic therapy, which began in the theater.  Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: https://windroserecovery.com/ Integrata:  www.integratahealing.com Dr. Chris Stauffer, MD, Director of SNaP Lab: https://www.chrisstauffermd.com/ Dr. Stauffer (he/they) is Associate Professor of Psychiatry at Oregon Health & Science University (OHSU) and dual board-certified in Psychiatry and Addiction Medicine. Dr. Stauffer is an OHSU medical school alum and completed Adult Psychiatry Residency and an Advanced Neuroscience Research Fellowship at the University of California, San Francisco (UCSF). Dr. Stauffer is an MDMA-assisted therapy supervisor, trainer, and educator, is a member of the Oregon Governor's Psilocybin Advisory Board, and has served as an expert psychedelic therapy consultant for various federal agencies. Dr. Stauffer has served in curriculum development, teaching, and mentorship roles for many programs, including the Center for Psychedelic Therapies and Research at the California Institute of Integral Studies, Integrative Psychiatry Institute’s Psychedelic-Assisted Therapy Training, and Naropa University’s Center for Psychedelic Studies.

    1h 21m

  5. MAY 6

    The Non-Ordinary States of IFS with Nick Brüss

    Dr. Chantelle Thomas and Nick Brüss chat about the common aims and integration of internal family systems therapy (IFS) and psychedelic-assisted therapy.  Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: https://windroserecovery.com/ Integrata:  www.integratahealing.com Nicholas Brüss, EdD, LMFT: https://psychedelic.support/network/nicholas-bruss-edd-lmft

    1h 16m

  6. APR 15

    Discussing Psychedelics in Recovery with Kevin Franciotti

    Dr. Chantelle Thomas and Kevin Franciotti have a wide ranging conversation about new opportunities, risks, and political implications of using psychedelics in recovery. Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: https://windroserecovery.com/ Integrata:  www.integratahealing.com Kevin Franciotti: https://www.kevinfranciotticounseling.com/

    1h 25m

  7. MAR 18

    KAP: Undissociating into Feeling

    Dr. Chantelle Thomas chats with Blind Spots producer Andrew Isham about her experience providing ketamine assisted psychotherapy (KAP) at Integrata. They also discuss what the direction of the podcast will be in 2024. Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: https://windroserecovery.com/ Integrata:  www.integratahealing.com Multidisciplinary Association for Psychedelic Studies: https://maps.org/ Polaris Insight Center: https://www.polarisinsight.com/ The Ketamine Training Center: https://theketaminetrainingcenter.com/ Psychedelic Research and Training Institute: https://pratigroup.org/

    1h 8m

  8. FEB 21

    Safely Excavating the Edges Within

    Dr. Chantelle Thomas connects with Dr. Willa Hall. They discuss their experiences facilitating psychedelic-assisted therapies.     Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: https://windroserecovery.com/   Dr. Willa Hall, Clinical Psychologist: https://www.nautilussanctuary.org/about#&gid=1326960091&pid=1

    1h 7m
See All (35)

Trailer

Ratings & Reviews

5
out of 5
21 Ratings

About

Exploring blind spots that exist in the cultural, relational, and therapeutic process, host Dr. Chantelle Thomas will have candid discussions that delve into the more challenging aspects of self-discovery. Filled with engaging and straightforward conversation, each episode features conversations with well-respected experts who examine what is commonly overlooked in the intricate and often inter-connected world of recovery, trauma and wellness. Join Windrose Recovery and its Executive Clinical Director Dr. Chantelle Thomas as we attempt to uncover barriers to personal growth from the perspective of both clients and clinicians.

Information

You Might Also Like

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada